Inhaled Antibiotic Therapy in Patients with COPD and Chronic Bronchial Infection (CBI) by P. aeruginosa: Mortality Analysis Based on Eradication vs. Persistence of CBI - Amsterdam 2025

Bronchiectasis: patient-centred outcomes and therapy

Chair(s): Yeon Mok Oh, William Flowers

Session type: Poster session

Inhaled Antibiotic Therapy in Patients with COPD and Chronic Bronchial Infection (CBI) by P. aeruginosa: Mortality Analysis Based on Eradication vs. Persistence of CBI

Fredy Bustamante Villanueva

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Linking daily symptoms to exacerbations in bronchiectasis: findings from the Bronchiectasis Health Questionnaire

Charlotte Schou

Poster

Abstract

Airway CD10/neprilysin is related to lung function and disease severity in patients with bronchiectasis: Preliminary data from the EMBARC BRIDGE study

Hannah Dickson

Poster

Abstract

Inhaled Antibiotic Therapy in Patients with COPD and Chronic Bronchial Infection (CBI) by P. aeruginosa: Mortality Analysis Based on Eradication vs. Persistence of CBI

Fredy Bustamante Villanueva

Abstract

Urinary and fecal dysfunction in bronchiectasis patients: a pilot study

Martina Santambrogio

Poster

Abstract

Sex and gender in bronchiectasis: an analysis of two Italian centres and a review of literature

Ilaria Giana

Poster

Abstract

A prospective UK study to evaluate the bronchiectasis impact measure in patients with bronchiectasis: data from the EMBARC-BRIDGE study

Holly Lind

Abstract

Pan-European validation of the Bronchiectasis Health Questionnaire: data from the EMBARC-BRIDGE study

Arietta Spinou

Poster

Abstract

Validation of bronchiectasis patient reported outcome measures in adults with primary ciliary dyskinesia: Data from the EMBARC-BRIDGE study and BEAT-PCD

Amelia Shoemark

Poster

Abstract

Characterising adult Primary ciliary dyskinesia (PCD) in the EMBARC-BRIDGE cohort

Amelia Shoemark

Poster

Abstract

Are postal sputum samples a valid tool for clinical and research applications in bronchiectasis?

Louise Jackson

Poster

Abstract

Evaluating the role of telerehabilitation in managing bronchiectasis: a randomized study

Büsra Öçal

Poster

Abstract

Performance of artificial intelligence answering questions on disease management from people with bronchiectasis: results from the AIR-BE study.

Mattia Nigro

Poster

Abstract

Association between participation in the German Bronchiectasis Registry (PROGNOSIS) and improvement in the course of disease

Pontus Mertsch

Poster

Abstract

Interleukin-17C governs interleukin-17A pathogenicity and orchestrates asthma endotype switching in bronchiectasis.

Yuwei Zhang

Poster

Abstract

Effectiveness of pulmonary rehabilitation in bronchiectasis patients: comparing airway clearance device and physical activity

Fabrizia La Torre

Poster

Abstract

Probabilistic modelling to mitigate AMR development in bronchiectasis an AMR-Lung study

Ollie Pitts

Poster

Abstract

Volatile organic compounds in patients with primary ciliary dyskinesia with or without prophylactic azithromycin

Akash Singh

Poster

Abstract

Bronchiectasis Patients' awareness on RSV-LRTI and attitude to vaccination.

Virginia Santello

Poster

Abstract

Ethnicity and socioeconomic status have no impact on longitudinal spirometry trend for children and young people (CYP) with non-cystic fibrosis bronchiectasis (NCFB)

Jui Prashant Andharia

Poster

Abstract

Steady state signs and symptoms of bronchiectasis in an international multicentre cohort: the 4S study

Mattia Nigro

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}